Search research articles
Contact Us
Filters
Showing results (81-90 of 107) with videos related to
Page
of 11
Sort By:
Cancer Reports (Hoboken, N.J.)
|
December 9, 2020
Comparison of the efficacy and safety of the EXTREME regimen for treating recurrent or metastatic head and neck squamous cell carcinoma in older and younger adult patients
Naoki Fukuda, Mayu Yunokawa, Yu Fujiwara, et al.
Anticancer Research
|
February 27, 2026
Real-world Analysis of Urinary Protein-to-Creatinine Ratio and Blood Pressure in Lenvatinib Therapy
Masanari Tsuji, Kazuo Kobayashi, Kazuyoshi Kawakami, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society
|
March 22, 2022
Assessment of Pazopanib-Related Heart Failure in Patients With Advanced Soft Tissue Sarcoma - A Single Institute Analysis
Xiaofei Wang, Kenji Nakano, Taro Shiga, et al.
Plos One
|
November 16, 2023
Factors associated with lenvatinib adherence in thyroid cancer and hepatocellular carcinoma
Yoshikazu Tateai, Kazuyoshi Kawakami, Minori Teramae, et al.
Investigational New Drugs
|
February 9, 2021
A first-in-human, phase 1 study of the NEDD8 activating enzyme E1 inhibitor TAS4464 in patients with advanced solid tumors
Noboru Yamamoto, Toshio Shimizu, Kan Yonemori, et al.
Human Gene Therapy
|
November 9, 2007
Osteopontin small interfering RNA protects mice from fulminant hepatitis
Yoshinari Saito, Shigeyuki Kon, Yukio Fujiwara, et al.
Cancer Management and Research
|
November 19, 2021
Clinical Impact of Cachexia in Head and Neck Cancer Patients Who Received Chemoradiotherapy
Naomi Hayashi, Yasuyoshi Sato, Yu Fujiwara, et al.
In Vivo (Athens, Greece)
|
September 3, 2020
Neutrophil-to-Lymphocyte Ratio as a Prognostic Marker for Anaplastic Thyroid Cancer Treated With Lenvatinib
Naoki Fukuda, Kazuhisa Toda, Y U Fujiwara, et al.
Anticancer Research
|
January 9, 2021
Pre-treatment Neutrophil-to-Lymphocyte Ratio Predicts Efficacy of Eribulin for Soft-tissue Sarcoma
Yasuyoshi Sato, Kenji Nakano, Naoki Fukuda, et al.
Endocrine
|
January 28, 2022
A proposed clinical scoring system for initiation of lenvatinib treatment in radioiodine-refractory thyroid cancer patients
Naoki Fukuda, Kazuhisa Toda, Shohei Udagawa, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 107) with videos related to
Sort By:
Page
of 11
Cancer Reports (Hoboken, N.J.)
|
December 9, 2020
Comparison of the efficacy and safety of the EXTREME regimen for treating recurrent or metastatic head and neck squamous cell carcinoma in older and younger adult patients
Naoki Fukuda, Mayu Yunokawa, Yu Fujiwara, et al.
Anticancer Research
|
February 27, 2026
Real-world Analysis of Urinary Protein-to-Creatinine Ratio and Blood Pressure in Lenvatinib Therapy
Masanari Tsuji, Kazuo Kobayashi, Kazuyoshi Kawakami, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society
|
March 22, 2022
Assessment of Pazopanib-Related Heart Failure in Patients With Advanced Soft Tissue Sarcoma - A Single Institute Analysis
Xiaofei Wang, Kenji Nakano, Taro Shiga, et al.
Plos One
|
November 16, 2023
Factors associated with lenvatinib adherence in thyroid cancer and hepatocellular carcinoma
Yoshikazu Tateai, Kazuyoshi Kawakami, Minori Teramae, et al.
Investigational New Drugs
|
February 9, 2021
A first-in-human, phase 1 study of the NEDD8 activating enzyme E1 inhibitor TAS4464 in patients with advanced solid tumors
Noboru Yamamoto, Toshio Shimizu, Kan Yonemori, et al.
Human Gene Therapy
|
November 9, 2007
Osteopontin small interfering RNA protects mice from fulminant hepatitis
Yoshinari Saito, Shigeyuki Kon, Yukio Fujiwara, et al.
Cancer Management and Research
|
November 19, 2021
Clinical Impact of Cachexia in Head and Neck Cancer Patients Who Received Chemoradiotherapy
Naomi Hayashi, Yasuyoshi Sato, Yu Fujiwara, et al.
In Vivo (Athens, Greece)
|
September 3, 2020
Neutrophil-to-Lymphocyte Ratio as a Prognostic Marker for Anaplastic Thyroid Cancer Treated With Lenvatinib
Naoki Fukuda, Kazuhisa Toda, Y U Fujiwara, et al.
Anticancer Research
|
January 9, 2021
Pre-treatment Neutrophil-to-Lymphocyte Ratio Predicts Efficacy of Eribulin for Soft-tissue Sarcoma
Yasuyoshi Sato, Kenji Nakano, Naoki Fukuda, et al.
Endocrine
|
January 28, 2022
A proposed clinical scoring system for initiation of lenvatinib treatment in radioiodine-refractory thyroid cancer patients
Naoki Fukuda, Kazuhisa Toda, Shohei Udagawa, et al.
Page
of 11